Ehlers-Danlos Syndromes: Comparison
Please note this is a comparison between Version 1 by Marcel Hanisch and Version 2 by Nicole Yin.

Ehlers–Danlos syndromes (EDS) are a clinically and genetically heterogeneous group of hereditary connective tissue disorders involving joint hyperlaxity, cutaneous hyperelasticity, and tissue fragility.

  • Ehlers Danlos
  • Rare Diseases
  • oral health

1. Introduction

A revised classification containing 13 subtypes was published by the International EDS Consortium, with a number of clinical conditions to guide and improve the diagnosis of each subtype[1] [2]. In the European Union, a disease is considered ‘rare’ if it affects fewer than one in two thousand people[2] [3]. In the case of EDS, the prevalence varies, depending on the type: between 1:30,000 (classical type) and < 1:1,000,000 (arthrochalasia type), whereas for the rarest form (the periodontitis type), the prevalence is unknown[3] [1].

EDS’ oral conditions have been described as periodontitis[1][4][5] [2,4,5], temporomandibular dysfunctions[1][6] [2,6], bleeding tendencies[7][8] [7,8], enamel hypoplasia[1][9] [2,9], shape abnormalities of the teeth and changes in the number of teeth[1][8] [2,8], a high palate[1][10] [2,10], dysgnathia, and malocclusion[1][11] [2,11], as well as decreased effects of local anesthesia[12][13] [12,13].

2. Latest Research, Data, Model, Management, Applications or Influences or …

Details about which area the research applies to or what kind of problems it can solve. Your insights, or hypotheses if necessary, regarding the research are also welcomed.